Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Managing endothelial dysfunction in COVID-19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double-blind, placebo-controlled, randomized clinical trial.
Matli K, Al Kotob A, Jamaleddine W, Al Osta S, Salameh P, Tabbikha R, Chamoun N, Moussawi A, Saad JM, Atwi G, Saad TA, Jamal O, Mokhbat J, Ghanem G. Matli K, et al. Among authors: tabbikha r. Clin Transl Sci. 2022 Oct;15(10):2323-2330. doi: 10.1111/cts.13369. Epub 2022 Jul 20. Clin Transl Sci. 2022. PMID: 35808843 Free PMC article. Clinical Trial.
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Emerging therapies in β-thalassemia: toward a new era in management.
Bou-Fakhredin R, Tabbikha R, Daadaa H, Taher AT. Bou-Fakhredin R, et al. Among authors: tabbikha r. Expert Opin Emerg Drugs. 2020 Jun;25(2):113-122. doi: 10.1080/14728214.2020.1752180. Epub 2020 Apr 15. Expert Opin Emerg Drugs. 2020. PMID: 32249632 Review.